Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1968 2
1969 1
1970 2
1971 3
1972 5
1973 2
1974 2
1975 6
1976 1
1977 2
1978 3
1979 5
1980 6
1981 3
1982 5
1983 4
1984 4
1985 8
1986 5
1987 9
1988 6
1989 12
1990 24
1991 20
1992 27
1993 24
1994 29
1995 26
1996 28
1997 33
1998 44
1999 44
2000 37
2001 44
2002 49
2003 54
2004 57
2005 53
2006 67
2007 67
2008 44
2009 58
2010 63
2011 82
2012 91
2013 135
2014 136
2015 157
2016 166
2017 147
2018 112
2019 105
2020 129
2021 134
2022 102
2023 77
2024 81
2025 64
2026 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,431 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.
Pengo V, Denas G, Zoppellaro G, Jose SP, Hoxha A, Ruffatti A, Andreoli L, Tincani A, Cenci C, Prisco D, Fierro T, Gresele P, Cafolla A, De Micheli V, Ghirarduzzi A, Tosetto A, Falanga A, Martinelli I, Testa S, Barcellona D, Gerosa M, Banzato A. Pengo V, et al. Blood. 2018 Sep 27;132(13):1365-1371. doi: 10.1182/blood-2018-04-848333. Epub 2018 Jul 12. Blood. 2018. PMID: 30002145 Free article. Clinical Trial.
Rivaroxaban is an effective and safe alternative to warfarin in patients with atrial fibrillation and venous thromboembolism. We tested the efficacy and safety of rivaroxaban compared with warfarin in high-risk patients with thrombotic antiphospholipid syndrome. ... …
Rivaroxaban is an effective and safe alternative to warfarin in patients with atrial fibrillation and venous thromboembolism. We test …
Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial .
Alcalai R, Butnaru A, Moravsky G, Yagel O, Rashad R, Ibrahimli M, Planer D, Amir O, Elbaz-Greener G, Leibowitz D. Alcalai R, et al. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 29;8(7):660-667. doi: 10.1093/ehjcvp/pvab057. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34279598 Clinical Trial.
In the warfarin group, two patients withdrew, and in the apixaban group one patient died. Thrombus completely resolved in 14 of 15 patients in the warfarin group and in 16 of 17 patients in the apixaban group (P = NS and P = 0.026 for non-inferiority). Two patients …
In the warfarin group, two patients withdrew, and in the apixaban group one patient died. Thrombus completely resolved in 14 of 15 pa …
Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis.
Chai-Adisaksopha C, Iorio A, Hillis C, Siegal D, Witt DM, Schulman S, Crowther M. Chai-Adisaksopha C, et al. Thromb Res. 2017 Dec;160:97-104. doi: 10.1016/j.thromres.2017.11.001. Epub 2017 Nov 11. Thromb Res. 2017. PMID: 29136562
BACKGROUND: This study aims to assess the effect of warfarin resumption in patients who experienced warfarin-associated intracranial hemorrhage (ICH). ...CONCLUSION: The study suggests that warfarin resumption is associated with significant reduction in ische …
BACKGROUND: This study aims to assess the effect of warfarin resumption in patients who experienced warfarin-associated intrac …
A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation.
Nin T, Sairaku A, Yoshida Y, Kamiya H, Tatematsu Y, Nanasato M, Inden Y, Hirayama H, Murohara T. Nin T, et al. Pacing Clin Electrophysiol. 2013 Feb;36(2):172-9. doi: 10.1111/pace.12036. Epub 2012 Nov 4. Pacing Clin Electrophysiol. 2013. PMID: 23121681 Clinical Trial.
A bridging therapy with heparin was not used in either of the patient groups. RESULTS: Dabigatran was switched to warfarin before the ablation because of dyspepsia in three patients. An occurrence of rebleeding from the venipuncture site was less common in dabigatran-alloc …
A bridging therapy with heparin was not used in either of the patient groups. RESULTS: Dabigatran was switched to warfarin before the …
Warfarin use increases bleeding risk in hemodialysis patients with atrial fibrillation: A meta-analysis of cohort studies.
Hussain S, Siddiqui AN, Baxi H, Habib A, Hussain MS, Najmi AK. Hussain S, et al. J Gastroenterol Hepatol. 2019 Jun;34(6):975-984. doi: 10.1111/jgh.14601. Epub 2019 Jan 29. J Gastroenterol Hepatol. 2019. PMID: 30614083
In the last decade, several epidemiological studies pointed out the risk of bleeding with the use of warfarin. So, this meta-analysis is aimed to assess the bleeding risk associated with the use of warfarin. ...RESULTS: A total of 15 studies, constituting a pooled s …
In the last decade, several epidemiological studies pointed out the risk of bleeding with the use of warfarin. So, this meta-analysis …
Warfarin Use and Risk of Stroke in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Meta-Analysis.
Lee M, Saver JL, Hong KS, Wu YL, Huang WH, Rao NM, Ovbiagele B. Lee M, et al. Medicine (Baltimore). 2016 Feb;95(6):e2741. doi: 10.1097/MD.0000000000002741. Medicine (Baltimore). 2016. PMID: 26871818 Free PMC article.
In spite of the substantial burden of atrial fibrillation and associated elevated ischemic stroke risk in patients undergoing hemodialysis, the role of warfarin in these high-risk patients remains uncertain. Our objective was to clarify the association between warfarin …
In spite of the substantial burden of atrial fibrillation and associated elevated ischemic stroke risk in patients undergoing hemodialysis, …
Genomewide association analysis of warfarin dose requirements in Middle Eastern and North African populations.
El Rouby N, Shahin MH, Bader L, Khalifa SI, Elewa H. El Rouby N, et al. Clin Transl Sci. 2022 Feb;15(2):558-566. doi: 10.1111/cts.13176. Epub 2021 Nov 2. Clin Transl Sci. 2022. PMID: 34729928 Free PMC article.
The genetic variants within VKORC1 rs9934438 and CYP2C9 rs4086116 explained 39% and 27% of the variability in the weekly warfarin dose requirement in the Qatari and Egyptians, respectively. This is the first GWAS of warfarin dose variability in the MENA region. It c …
The genetic variants within VKORC1 rs9934438 and CYP2C9 rs4086116 explained 39% and 27% of the variability in the weekly warfarin dos …
Warfarin and Aspirin Versus Warfarin Alone in Patients With HeartMate 3 Left Ventricular Assist Device: A Systematic Review and Meta-Analysis.
Viana P, Lopes LM, Cabral TDD, Persson J, Tapioca VO, Freire CVS, Relvas JH, Mesquita Y, Marques IR, Gomes WF. Viana P, et al. Pacing Clin Electrophysiol. 2025 Jan;48(1):53-58. doi: 10.1111/pace.15110. Epub 2024 Nov 20. Pacing Clin Electrophysiol. 2025. PMID: 39565678
We performed a systematic review and meta-analysis assessing the impact of combined ASA and warfarin therapy compared to warfarin alone on the incidence of non-surgical bleeding events in patients with HM3 LVAD. METHODS: MEDLINE, Embase, and Cochrane databases were …
We performed a systematic review and meta-analysis assessing the impact of combined ASA and warfarin therapy compared to warfarin …
Warfarin use and the risks of stroke and bleeding in hemodialysis patients with atrial fibrillation: A systematic review and a meta-analysis.
Li J, Wang L, Hu J, Xu G. Li J, et al. Nutr Metab Cardiovasc Dis. 2015 Aug;25(8):706-13. doi: 10.1016/j.numecd.2015.03.013. Epub 2015 Apr 1. Nutr Metab Cardiovasc Dis. 2015. PMID: 26026205
BACKGROUND AND AIM: The efficacy and safety of warfarin therapy in hemodialysis (HD) patients with atrial fibrillation (AF) remains controversial. ...CONCLUSION: This meta-analysis suggested that warfarin should not be recommended for the routine treatment of HD pat …
BACKGROUND AND AIM: The efficacy and safety of warfarin therapy in hemodialysis (HD) patients with atrial fibrillation (AF) remains c …
Warfarin Dosing Algorithms Underpredict Dose Requirements in Patients Requiring 7 mg Daily: A Systematic Review and Meta-analysis.
Saffian SM, Duffull SB, Wright D. Saffian SM, et al. Clin Pharmacol Ther. 2017 Aug;102(2):297-304. doi: 10.1002/cpt.649. Clin Pharmacol Ther. 2017. PMID: 28160278
There is preliminary evidence to suggest that some published warfarin dosing algorithms produce biased maintenance dose predictions in patients who require higher than average doses. ...The meta-analysis included 47 evaluations of 22 different warfarin dosing algori …
There is preliminary evidence to suggest that some published warfarin dosing algorithms produce biased maintenance dose predictions i …
2,431 results